EDGAR Filing Documents for 0001875620-21-000002

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0001875620-21-000002

Filing Date

2021-08-03

Accepted

2021-08-03 14:18:03

Documents

Effectiveness Date

2021-08-03

Items

Item 06c:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	7775
	Complete submission text file	0001875620-21-000002.txt		8998

Mailing Address C/O SANDS CAPITAL VENTURES, LLC 1000 WILSON BOULEVARD, SUITE 3000 ARLINGTON VA 22209

Business Address C/O SANDS CAPITAL VENTURES, LLC 1000 WILSON BOULEVARD, SUITE 3000 ARLINGTON VA 22209 703-562-4000

Sands Capital Life Sciences Pulse Fund II, L.P. (Filer) CIK: 0001875620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
Type: D | Act: 33 | File No.: 021-408624 | Film No.: 211139034